Change and growth in our health care system are driven not only by federal and state regulations and legislation but also by private sector entrepreneurs who strive to expand choice, identify new treatments, and develop cures.
The U.S. Chamber of Commerce’s Equality of Opportunity Initiative in partnership with the Chamber’s Discover & Deliver campaign, invites you to Equality of Opportunity in Action: Bridging the Racial Gap for COVID-19 Treatments and Vaccines on Tuesday, February 16 at 1:00 PM EST.
This Letter was sent to the President of the United States and to the Members of the United States Congress, on the Administration's "American Rescue Plan" and the Chamber's priorities for a bipartisan COVID-19 relief package.
This Hill Letter was sent to the Senate Committee on Homeland Security and Governmental Affairs, on the nomination of Alejandro Mayorkas to be Secretary of the Department of Homeland Security.
The latest on Operation Warp Speed from General Paul Ostrowski, director of supply, production and distribution for the program.
WASHINGTON, D.C. - U.S. Chamber of Commerce President Suzanne P. Clark today released the following statement regarding the Food and Drug Administration decision to grant an Emergency Use Authorization for Pfizer and BioNTech’s COVID-19 vaccine:
The U.S. Chamber will challenge this flawed and harmful policy
Our VP of Health Policy explains why Congress should strengthen employer-sponsored insurance rather than a create a public option.
Please join us for a discussion with business and policy leaders from across the country on the evolution of the employer-sponsored insurance (ESI) market and the future of this important coverage option for 180 million Americans. During the event we will unveil new research insights into the impact of a public option or Medicare buy-in on employees’ coverage.
This paper discusses recent proposals to expand Medicare and lays out the likely impact such a move would have on various stakeholders. For the sake of simplicity, this paper discusses Medicare for all and Medicare buy-in proposals, but the points apply more broadly.
The U.S. bio-pharmaceutical sector is committed to fighting COVID-19, but imposing artificial price controls could impede progress.
From shipping to staffing, the Chamber and its partners have the tools to save your business money and the solutions to help you run it more efficiently. Join the U.S. Chamber of Commerce today to start saving.
